Raymond James Financial Services Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $222M | Buy |
1,124,281
+32,129
| +3% | +$6M | 0.3% | 69 |
|
|
2024
Q2 | $187M | Sell |
1,092,152
-3,622
| -0.3% | -$600K | 0.27% | 80 |
|
|
2024
Q1 | $200M | Buy |
1,095,774
+18,438
| +2% | +$3.18M | 0.3% | 72 |
|
|
2023
Q4 | $167M | Buy |
1,077,336
+25,135
| +2% | +$3.66M | 0.27% | 72 |
|
|
2023
Q3 | $157M | Sell |
1,052,201
-32,227
| -3% | -$4.73M | 0.28% | 70 |
|
|
2023
Q2 | $146M | Buy |
1,084,428
+25,706
| +2% | +$3.77M | 0.26% | 81 |
|
|
2023
Q1 | $169M | Sell |
1,058,722
-155,853
| -13% | -$23.8M | 0.32% | 65 |
|
|
2022
Q4 | $196M | Sell |
1,214,575
-30,367
| -2% | -$4.66M | 0.39% | 52 |
|
|
2022
Q3 | $167M | Buy |
1,244,942
+28,212
| +2% | +$4.05M | 0.37% | 52 |
|
|
2022
Q2 | $186M | Sell |
1,216,730
-100,256
| -8% | -$15.3M | 0.41% | 47 |
|
|
2022
Q1 | $213M | Buy |
1,316,986
+66,167
| +5% | +$9.61M | 0.4% | 45 |
|
|
2021
Q4 | $169M | Buy |
1,250,819
+28,703
| +2% | +$3.39M | 0.32% | 65 |
|
|
2021
Q3 | $132M | Buy |
1,222,116
+19,631
| +2% | +$2.24M | 0.27% | 73 |
|
|
2021
Q2 | $135M | Buy |
1,202,485
+47,254
| +4% | +$5.32M | 0.28% | 73 |
|
|
2021
Q1 | $125M | Buy |
1,155,231
+94,674
| +9% | +$10.1M | 0.28% | 72 |
|
|
2020
Q4 | $114M | Buy |
1,060,557
+133,760
| +14% | +$12.9M | 0.28% | 72 |
|
|
2020
Q3 | $81.2M | Buy |
926,797
+24,500
| +3% | +$2.31M | 0.23% | 91 |
|
|
2020
Q2 | $88.6M | Buy |
902,297
+83,348
| +10% | +$7.34M | 0.28% | 72 |
|
|
2020
Q1 | $62.4M | Buy |
818,949
+51,823
| +7% | +$4.41M | 0.27% | 80 |
|
|
2019
Q4 | $67.9M | Buy |
767,126
+87,611
| +13% | +$7.27M | 0.22% | 97 |
|
|
2019
Q3 | $51.5M | Sell |
679,515
-103,021
| -13% | -$7.06M | 0.19% | 114 |
|
|
2019
Q2 | $56.9M | Sell |
782,536
-858,664
| -52% | -$67.5M | 0.22% | 95 |
|
|
2019
Q1 | $132M | Buy |
1,641,200
+167,199
| +11% | +$13.7M | 0.55% | 31 |
|
|
2018
Q4 | $136M | Buy |
1,474,001
+143,209
| +11% | +$12.6M | 0.72% | 23 |
|
|
2018
Q3 | $126M | Buy |
1,330,792
+34,901
| +3% | +$3.31M | 0.57% | 26 |
|
|
2018
Q2 | $120M | Buy |
1,295,891
+76,962
| +6% | +$7.52M | 0.61% | 23 |
|
|
2018
Q1 | $115M | Buy |
1,218,929
+47,277
| +4% | +$5.19M | 0.66% | 22 |
|
|
2017
Q4 | $113M | Buy |
1,171,652
+45,920
| +4% | +$4.33M | 0.71% | 20 |
|
|
2017
Q3 | $100M | Buy |
1,125,732
+27,106
| +2% | +$2.06M | 0.64% | 23 |
|
|
2017
Q2 | $79.7M | Buy |
1,098,626
+113,245
| +11% | +$7.61M | 0.55% | 27 |
|
|
2017
Q1 | $64.2M | Buy |
985,381
+151,917
| +18% | +$9.55M | 0.49% | 35 |
|
|
2016
Q4 | $52.2M | Buy |
833,464
+363,937
| +78% | +$22.2M | 0.44% | 37 |
|
|
2016
Q3 | $29.6M | Sell |
469,527
-12,315
| -3% | -$797K | 0.26% | 84 |
|
|
2016
Q2 | $29.8M | Buy |
481,842
+55,609
| +13% | +$3.39M | 0.29% | 72 |
|
|
2016
Q1 | $24.3M | Buy |
426,233
+19,801
| +5% | +$1.1M | 0.28% | 79 |
|
|
2015
Q4 | $24.1M | Buy |
406,432
+73,113
| +22% | +$4.21M | 0.28% | 83 |
|
|
2015
Q3 | $18.1M | Buy |
333,319
+222,651
| +201% | +$14.5M | 0.3% | 75 |
|
|
2015
Q2 | $7.44M | Buy |
110,668
+75,679
| +216% | +$4.94M | 0.53% | 37 |
|
|
2015
Q1 | $2.05M | Buy |
34,989
+641
| +2% | +$38.7K | 0.1% | 233 |
|
|
2014
Q4 | $2.25M | Sell |
34,348
-3,425
| -9% | -$216K | 0.12% | 211 |
|
|
2014
Q3 | $2.18M | Sell |
37,773
-139
| -0.4% | -$7.72K | 0.12% | 213 |
|
|
2014
Q2 | $2.14M | Sell |
37,912
-1,490
| -4% | -$78.2K | 0.13% | 200 |
|
|
2014
Q1 | $2.02M | Sell |
39,402
-1,609
| -4% | -$81.3K | 0.12% | 211 |
|
|
2013
Q4 | $2.17M | Sell |
41,011
-5,994
| -13% | -$295K | 0.13% | 193 |
|
|
2013
Q3 | $2.1M | Sell |
47,005
-144,254
| -75% | -$6.39M | 0.14% | 184 |
|
|
2013
Q2 | $7.91M | Buy |
+191,259
| New | +$8.36M | 0.23% | 95 |
|
Other funds holding ABBV
Raymond James Financial Services Advisors's ABBV Position: Q3 2024 in Review
Raymond James Financial Services Advisors increased its AbbVie (ABBV) stake by 2.9% in Q3 2024, buying an estimated $6M and bringing the position to 1,124,281 shares worth $222M. The position accounts for 0.3% of the portfolio, ranked #69.
Raymond James Financial Services Advisors first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. 3,499 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Raymond James Financial Services Advisors held 1,124,281 shares of AbbVie worth $222M as of Q3 2024.
- Raymond James Financial Services Advisors bought 32,129 AbbVie shares in Q3 2024, an estimated $6M.
- AbbVie made up 0.3% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #69 holding.
- Raymond James Financial Services Advisors first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
- 3,499 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.